NovaStar Capital

About The Fund

NovaStar Capital is a venture capital firm headquartered at 1290 Avenue of the Americas, New York, New York, 10104, United States. They specialize in a range of investment stages, including Seed, Startup, Early Stage, Expansion, and Later Stage financing. With expertise in equity and fund of funds, NovaStar Capital focuses on industries such as BioTech, HealthTech (& Fitness), and Medical Devices (& Hospital Services). Their approach involves deploying capital with a minimum investment of $300,000 and a maximum of $20,000,000 to support innovative companies in their respective fields. As a Venture Capital Fund, they manage assets totaling approximately $450 million. Their aim is to guide companies through critical phases of growth, leveraging their industry expertise and resources to help portfolio firms achieve market share growth and expand geographically. NovaStar Capital provides not just financial support but also strategic guidance, helping its partners scale effectively and succeed in a competitive marketplace. This aligns with the success stories and testimonials of their portfolio companies, as evidenced by the content found on the provided website, which also goes by the name AXA Venture Partners (AVP). AVP showcases a significant track record in supporting organizations to scale effectively and partner with them for ambitious market share growth and geographic expansion goals. AVP has invested in enterprise software, fintech/insurtech, digital health, consumer tech, and supports growth in sectors undergoing technological transformations. Their investment platform is global, evidenced by offices in New York, London, and Paris, and includes a distinctive network of LPs, including strategic partnerships for business development, articulating a value proposition around multi-stage investment remit, global platform, and unique access to networks.